KATP channel blocker to treat glaucoma

Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost

Costagliola Ciro
Campa Claudio
Perri Paolo
Parmeggiani Francesco
Incorvaia Carlo
ROMANO, MARIO

January 2008

Purpose: To verify the influence of a non-steroidal anti-inflammatory drug (NSAID), ketorolac (topic...

Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients

Caruso C.
Pacente L.
Troiano P.
Ostacolo C.
D'Andrea L.
Bartollino S.
Costagliola C.

January 2020

Purpose: To assess the ocular hypotensive effect of 15-keto fluprostenol, the oxidized metabolite of...

Novel ocular antihypertensive compounds in clinical trials

Chen J
Runyan SA
Robinson MR

May 2011

June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...

KATP channel blocker to treat glaucoma

Thumann, Gabriele
Lorincz, Erika
Lorincz, Erika

Paper: Tolbutamide Eye Drops Increase Aqueous Humor Outflow and Lower Intraocular Pressure: A Proof-...

Tolbutamide eye drops increase aqueous humor outflow and lower intraocular pressure: a proof of concept for glaucoma treatment

Thumann, Gabriele
Sorgente, Nino
Kropp, Martina
Jonescu-Cuypers, Christian Paul

January 2021

Background: Glaucoma refers to a heterogeneous group of diseases characterized by retinal cell degen...

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma

Liu Y
Mao W

December 2012

Yang Liu, Weiming MaoDepartment of Cell Biology and Anatomy, North Texas Eye Research Institute, Uni...

Effect of potassium channel openers in acute and chronic models of glaucoma

Panchal, Shital S.
Mehta, Anita A.
Santani, Devdas D.

September 2016

AbstractPurposeGlaucoma is characterized by increased intraocular pressure (IOP). The effect of nico...

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma

Jayanetti V
Sandhu S
Lusthaus JA

November 2020

Viran Jayanetti,1 Sartaj Sandhu,2 Jed A Lusthaus3 1Prince of Wales Hospital, Sydney, New South Wales...

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

Dorota Pozarowska

October 2010

Dorota PozarowskaDepartment of Ophthalmology, Medical University, Lublin, PolandAbstract: Glaucoma i...

GEL-FORMING EYE DROPS FOR ENHANCED INTRAOCULAR PRESSURE LOWERING FOR TREATMENT OF GLAUCOMA

Kwon, HyeYoung

June 2020

Glaucoma is one of the leading causes of blindness worldwide. Glaucoma develops as a result of an im...

The Effect Of Preservative Free Tafluprost On Intraocular Pressure In Patients With Ocular Hypertension Or Primary Open Angle Glaucoma

Hommer A
Kromus M
Schmidl D
Garhofer G
Schmetterer L

April 2015

Purpose: Increased intraocular pressure (IOP) is the most important modifiable risk factor for the d...

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date

Dasso L
Al-Khaled T
Sonty S
Aref AA

October 2018

Lily Dasso, Tala Al-Khaled, Sriram Sonty, Ahmad A Aref Department of Ophthalmology and Visual Scien...

Glaucoma - Pharmacological treatment

Worsley, A
Husband, A

January 2005

Pharmacological treatment for glaucoma is directed at reducing intraocular pressure (IOP), the main ...

Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma

Aspberg, Johan
Heijl, Anders
Jóhannesson, Gauti
Lindén, Christina
Andersson, Sabina
Bengtsson, Boel

August 2018

Purpose:To assess the intraocular pressure (IOP)-reducing effect of latanoprost in treatment-naïve p...

Recent Advances in Pharmacotherapy of Glaucoma

Gupta, S.K.
Galpalli, Niranjan D.
Agrawal, S.S.
Srivastava, Sushma
Saxena, Rohit

October 2009

Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve...

Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost

Costagliola Ciro
Campa Claudio
Perri Paolo
Parmeggiani Francesco
Incorvaia Carlo
ROMANO, MARIO

January 2008

Purpose: To verify the influence of a non-steroidal anti-inflammatory drug (NSAID), ketorolac (topic...

Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients

Caruso C.
Pacente L.
Troiano P.
Ostacolo C.
D'Andrea L.
Bartollino S.
Costagliola C.

January 2020

Purpose: To assess the ocular hypotensive effect of 15-keto fluprostenol, the oxidized metabolite of...

Novel ocular antihypertensive compounds in clinical trials

Chen J
Runyan SA
Robinson MR

May 2011

June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...

KATP channel blocker to treat glaucoma

Thumann, Gabriele
Lorincz, Erika
Lorincz, Erika

Paper: Tolbutamide Eye Drops Increase Aqueous Humor Outflow and Lower Intraocular Pressure: A Proof-...

Tolbutamide eye drops increase aqueous humor outflow and lower intraocular pressure: a proof of concept for glaucoma treatment

Thumann, Gabriele
Sorgente, Nino
Kropp, Martina
Jonescu-Cuypers, Christian Paul

January 2021

Background: Glaucoma refers to a heterogeneous group of diseases characterized by retinal cell degen...

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma

Liu Y
Mao W

December 2012

Yang Liu, Weiming MaoDepartment of Cell Biology and Anatomy, North Texas Eye Research Institute, Uni...

Effect of potassium channel openers in acute and chronic models of glaucoma

Panchal, Shital S.
Mehta, Anita A.
Santani, Devdas D.

September 2016

AbstractPurposeGlaucoma is characterized by increased intraocular pressure (IOP). The effect of nico...

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma

Jayanetti V
Sandhu S
Lusthaus JA

November 2020

Viran Jayanetti,1 Sartaj Sandhu,2 Jed A Lusthaus3 1Prince of Wales Hospital, Sydney, New South Wales...

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

Dorota Pozarowska

October 2010

Dorota PozarowskaDepartment of Ophthalmology, Medical University, Lublin, PolandAbstract: Glaucoma i...

GEL-FORMING EYE DROPS FOR ENHANCED INTRAOCULAR PRESSURE LOWERING FOR TREATMENT OF GLAUCOMA

Kwon, HyeYoung

June 2020

Glaucoma is one of the leading causes of blindness worldwide. Glaucoma develops as a result of an im...

The Effect Of Preservative Free Tafluprost On Intraocular Pressure In Patients With Ocular Hypertension Or Primary Open Angle Glaucoma

Hommer A
Kromus M
Schmidl D
Garhofer G
Schmetterer L

April 2015

Purpose: Increased intraocular pressure (IOP) is the most important modifiable risk factor for the d...

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date

Dasso L
Al-Khaled T
Sonty S
Aref AA

October 2018

Lily Dasso, Tala Al-Khaled, Sriram Sonty, Ahmad A Aref Department of Ophthalmology and Visual Scien...

Glaucoma - Pharmacological treatment

Worsley, A
Husband, A

January 2005

Pharmacological treatment for glaucoma is directed at reducing intraocular pressure (IOP), the main ...

Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma

Aspberg, Johan
Heijl, Anders
Jóhannesson, Gauti
Lindén, Christina
Andersson, Sabina
Bengtsson, Boel

August 2018

Purpose:To assess the intraocular pressure (IOP)-reducing effect of latanoprost in treatment-naïve p...

Recent Advances in Pharmacotherapy of Glaucoma

Gupta, S.K.
Galpalli, Niranjan D.
Agrawal, S.S.
Srivastava, Sushma
Saxena, Rohit

October 2009

Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve...

Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost

Costagliola Ciro
Campa Claudio
Perri Paolo
Parmeggiani Francesco
Incorvaia Carlo
ROMANO, MARIO

January 2008

Purpose: To verify the influence of a non-steroidal anti-inflammatory drug (NSAID), ketorolac (topic...

Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients

Caruso C.
Pacente L.
Troiano P.
Ostacolo C.
D'Andrea L.
Bartollino S.
Costagliola C.

January 2020

Purpose: To assess the ocular hypotensive effect of 15-keto fluprostenol, the oxidized metabolite of...

Novel ocular antihypertensive compounds in clinical trials

Chen J
Runyan SA
Robinson MR

May 2011

June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...

KATP channel blocker to treat glaucoma

Abstract

Extracted data

KATP channel blocker to treat glaucoma

Abstract

Extracted data

Related items

Related items